Introduction
The administration of intrapartum antibiotic prophylaxis (IAP) effectively reduces the incidence of neonatal earlyonset group B streptococcal (GBS) infections. Yet, earlyonset GBS infection remains a significant cause of neonatal morbidity and mortality (1) (2) (3) . The strategies for IAP administration are based on prenatal screening, i.e. detection of GBS in the woman's recto/vaginal flora ª 2017 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 96 (2017) [1475] [1476] [1477] [1478] [1479] [1480] [1481] [1482] [1483] in late pregnancy, or the presence of risk factors for neonatal infection during labor. Typically, penicillin G is given repeatedly from onset of labor until delivery (4) . In the US and in many European countries IAP is based on screening in late pregnancy, with administration of the antibiotic to all parturients who screened positive (5) . Some countries, such as New Zealand, Norway, the Netherlands, Sweden, and the UK advocate IAP only to women with risk factors known to substantially increase the risk for neonatal infection (6) (7) (8) (9) (10) . The efficacy of the two approaches has never been compared in prospective randomized studies and the opportunity to perform such investigations no longer appears feasible (11, 12) . There are pros and cons with both prophylactic strategies. With screening, the prediction of GBS colonization at labor is also limited when specimens are collected at 35-37 weeks' gestation as recommended (13) (14) (15) . The administration of IAP to all GBS-positive women also unnecessarily exposes a large group of women and newborns to antibiotics. In Sweden with a GBS prevalence in women in labor of approximately 30% (16) and an incidence of neonatal early-onset GBS sepsis of 0.4& (17) , the number of women needed to treat to prevent one neonatal case would be approximately 750. The major drawback of the risk-based strategy is that around 40% of case mothers in Sweden present with no risk factors. To some extent this downside may be balanced by a better prognosis in such cases, primarily because that preterm infants are not included (17) .
In Sweden there were no national guidelines for the prevention of early-onset GBS disease before 2008, although risk-based IAP was already used in some delivery units. A consensus committee reached a decision to promote the risk-based policy essentially as described by the U.S. Center for Disease Control (4). The national guidelines were endorsed by the National Board of Health and Welfare in the spring of 2008 (9) . The aims of the present study were to investigate the incidence of neonatal early-onset GBS morbidity before and after the guidelines were issued, and to evaluate the presence of risk factors in case mothers and the timeliness of IAP administration.
Material and methods
National health registers (Swedish Neonatal Quality Register, Medical Birth Register, Patient Register and Cause of Death Register) were searched for infants with diagnoses of early-onset GBS morbidity (ICD-10 codes P36.0, Neonatal group B streptococcal sepsis; P23.3, Neonatal group B streptococcal pneumonia; G00.2, Meningitis caused by streptococci). In addition, local registers of all clinical microbiology laboratories were asked to retrieve data on blood and/or cerebrospinal fluid cultures positive for GBS in the appropriate group of patients. Early-onset was defined as infection debut within the first week of life (days 0-6). The Swedish Neonatal Quality register is a national neonatal network run by the profession with support from medical care providers to which all units caring for newborn infants report (18) . The Medical Birth Register, The Patient Register, and The Cause of Death Register are run by the National Board of Health and Welfare and it is mandatory for all units providing medical care to report to these registers. The registers identify the infant and the mother by unique personal identification numbers. However, in some cases infants may have been given a provisional identification number when the assignment to a unique personal number was delayed.
In infants with a purported diagnosis of early-onset GBS infection, medical records from the relevant admission were retrieved from the local hospitals. Maternal records from the germane pregnancy/delivery were also requested. The medical records were abstracted by two of the authors (S.H. and M.L.) and data were entered into a database for analysis. When data were ambiguous, consensus was reached after discussion or after request of complementary data from the health providing unit. Early-onset GBS infection was considered verified if culture from blood and/or cerebrospinal fluid was positive for GBS. In clinical sepsis, cultures from blood or cerebrospinal fluid were negative but relevant symptoms and/ or a C-reactive protein level of at least 25 mg/L were required and, as well, a finding of GBS in vaginal/rectal swabs from the mother or superficial cultures from the infant. An additional criterion to be fulfilled was the initiation of antibiotic therapy in the infant. A diagnosis of GBS pneumonia also required a pulmonary X-ray compatible with infectious pneumonia.
Maternal records were abstracted for the presence of any of the risk factors defined (rupture of membranes ≥18 h, temperature in labor ≥38.0°C, preterm labor <37 weeks, history of GBS bacteriuria during pregnancy, and previous infant with GBS morbidity) and the time spans from
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There was a significant 50% reduction of early-onset group B streptococcal infection in infants of women with one or more defined risk factors at parturition after implementation of risk-based intrapartum antibiotic prophylaxis. However, there were also several occasions where intrapartum antibiotic prophylaxis was indicated but not given. admission to delivery, from onset of labor to delivery, and from rupture of membranes to delivery were recorded. Details of the administration and duration of IAP were ascertained and mode of delivery was recorded. In the analysis, adequate IAP was defined as a duration of four or more hours, suboptimal two to less than four hours, and inadequate less than two hours. A query was also distributed to the delivery units asking when the guidelines for risk-based IAP had actually been implemented. . When paired data were available for mothers and infants the analysis covered the whole group as well as the subgroups with or without risk factor present.
Statistical analyses
A second series of analysis were done adjusting the comparison for the point of time from which the unit actually deployed the guidelines (Supporting Information Table S1 ). For these analyses, the Mantel-Haenzsel procedure (19) was used to obtain ORs (pre-guideline vs. post-guideline implementation), stratified for maternity unit and delivery mode. Miettinen's method was used to obtain 95% confidence intervals (20) . Included in these analyses were all cases with unique identification whose records could be linked with the MBR. The control group consisted of all other births. One subanalysis was performed that included pregnancies with at least one risk factor. For the cases, information on risk factors was obtained from the detailed case records. For the controls, and for cases for whom maternal information was not available in the case file, information on risk factors was gathered from the MBR using ICD10 codes as a proxy for the risk factors defined. The diagnoses used were premature rupture of the membranes (ICD10-codes O42 or O756), amnio-chorionitis (O411), and information on gestational age (<37 completed weeks).
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Results
A total of 531 case records were requested and 509 could be retrieved from the different sources (96%) (Figure 1 ).
Neither maternal nor infant data could be retrieved for 22 requested records. Infant records were missing for 25 maternal records and maternal records for 26 infant records. There were 458 complete mother/infant pairs. In 17 infant cases, a laboratory report of a positive blood or cerebrospinal fluid culture could not be linked to a specific infant with the clinical records available. These were included as unique cases. The number of live births in Sweden during the periods 2006-2008 and 2009-2011 were 317 281 and 334 593, respectively, with a stable proportion of preterm infants (<37 weeks) of 6.0 and 6.1% (21) . In 14 of the 45 delivery units, the preventive strategy with risk-based IAP had been deployed before the official guidelines from the National Board for Health and Welfare were issued in March 2008. Nineteen units started gradually deploying the guidelines during the remains of that year and 12 delivery units adapted to the guidelines the years thereafter, the latest in September 2011.
The number of infants with GBS morbidity was based on records of the infant and laboratory reports (n = 501). There were 227 cases of verified early-onset GBS sepsis and 168 cases with clinical infection where cultures from blood and CSF were negative. In 106 cases the criteria for verified or clinical GBS infection were not fulfilled. In the statistical evaluation by division per time periods (analysis A), Table 1 , there was a significant reduction in the number of infant cases during time period 2. The incidence of infants with verified sepsis was 0.40/1000 live births in period 1 (127/317 281) and 0.30 (100/334 593) in period 2 [odds ratio (OR) 0.75, 95% confidence interval (CI) 0.57-0.99]. The incidences of any GBS morbidity (verified or clinical infection) per time period were 0.73/ 1000 and 0.49/1000 live births, respectively (OR 0.67, 95% CI 0.55-0.83). In parturients with at least one risk factor, the OR for verified infection was 0.66 in period 2 (95% CI 0.43-1.00). The OR for any GBS morbidity in infants of these women was 0.55 (95% CI 0.41-0.74). The OR for early-onset GBS infection in infants of mothers without risk factors was unchanged.
Analyses were also done comparing the results for each maternity unit according to the point of time from which the unit deployed the guidelines (analysis B) ( Figure 2 , Table S1 ). Adjustments were made for maternity unit and mode of delivery. The adjusted ORs for verified sepsis and any GBS morbidity (verified or clinical infection), after compared with before implementation of the guidelines, were 0.74 (95% CI 0.53-1.03) and 0.70 (95% CI 0.55-0.88), respectively. For infants of mothers with at least one risk factor, the corresponding adjusted ORs (before vs. after implementation) for verified and any GBS morbidity were 0.52 (95% CI 0.35-0.77) and 0.47 (95% CI 0.35-0.64), respectively. In total, there were 100 infants with verified sepsis in mothers with one or more risk factors (Table 2) . In five parturients, adequate IAP was administered during four or more hours, and all of these women had the same two risk factors: rupture of membranes ≥18 h and fever ≥38°C. There were no fatal cases among these infants where adequate IAP failed. In all, there were eight fatal cases for which paired maternal and infant records were available. In six of these, no IAP had been given and in two, the duration of IAP was less than two hours. In three of the fatal cases, labor was imminent and parturition occurred less than two hours after admission to the labor ward. In five cases, there would probably have been time for the administration of IAP. There was one fatal case, born at 29 weeks' gestational age, among infants with clinical disease where the mother had been given adequate IAP. A significantly larger proportion of infants with clinical sepsis had mothers given any IAP (59/163, 36%) as compared with infants with verified sepsis (16/192, 8 .3%), p < 0.001. There were 20 infant cases with GBS meningitis, 15 in period 1 and five in period 2. In all these cases, the blood culture was also positive. In none of the mothers with at least one risk factor and infants with meningitis, had any IAP been administered (n = 5). In all there were 14 cases of meningitis in infants born to mothers without risk factors.
In all, 63% of verified or clinical cases (247/395) occurred within the first day of life and 96% (380/395) within three days after birth (Figure 3 ). In the cohort studied, 106 cases (21%) with abstracted records did not fulfill the criteria for early-onset GBS infection. The number of dismissed cases did not differ significantly during the two time periods (55 vs. 51).
Among 379 cases with any early-onset GBS morbidity and known gestational age at birth 92 infants (24%) were born preterm (<37 completed weeks) (Figure 4 ). The proportion of preterm infants with verified sepsis was larger in period 1 than in period 2 (29% vs. 19%), but the difference was not significant.
The proportion of women with risk factors and infants with any GBS morbidity was 57% (201/355), thus no risk There were in total 11 deaths among cases with verified sepsis, yielding a mortality of 4.8% (11/227, 95% CI 2.1-7.6) ( Table 2 ). The death rate in the group of infants to mothers with at least one risk factor was 8% (8/100) and in infants of mothers with no risk factor, 3.2% (3/92). This difference was not significant. The number of deaths by time periods 1 and 2 were six and five, respectively. In period 1 there were two deaths probably attributable to early-onset GBS disease in cases with clinical sepsis (2/168, 1.1%) and both these infants were born preterm (gestational age 29 and 30 weeks). In period 2 there were no deaths in infants with clinical sepsis. During the period 2006-2011 there were 211 infants with known gestational age at birth and verified sepsis. Six deaths occurred among 56 preterm infants (18%). In term infants, the mortality rate was 5/155 (3.2%).
There were 94 cases with early-onset GBS morbidity and risk factor present, occurring after local implementation of guidelines (Table 3 ). In 91 of these, data on duration of labor and timeliness of IAP administration were available. There were 19 cases where adequate IAP was administered (four or more hours). In 13 and 10 cases, respectively, the duration of IAP was suboptimal (two to less than four hours) or inadequate (less than two hours). No IAP was administered in 49 cases. In 52 of the 72 cases with suboptimal, inadequate or nil IAP administered, the duration of labor was three or more hours. In Figure 2 . Odds ratio (OR) for neonatal early-onset group B streptococcal infection, verified and clinical cases, before and after implementation of risk-based intrapartum antibiotic prophylaxis guidelines. RF, risk factor. Table 2 . Early-onset group B streptococcal (GBS) infection cases per time period and intrapartum antibiotic prophylaxis (IAP) administration. Case numbers and percent (%). Based on records from complete mother/infant dyads (n = 458).
Risk factor ≥1
Verified sepsis/ meningitis n (%) 34 of these cases the duration of labor was five hours or longer. Among 355 parturients with maternal records available and infants with any GBS morbidity, the mode of delivery was influenced by the presence of risk factors, and an increased proportion of abdominal deliveries in women with risk factors was observed (Table 4) .
Discussion
The main finding of this study is the significant reduction of early-onset GBS infection in infants of parturients presenting with risk factors. This reduction occurred after the national guidelines for risk-based IAP administration had been issued. Before this precept was delivered by health authorities to care providers in 2008, local clinical guidelines for this preventive strategy existed to varying degrees. Therefore, we analyzed the data not only with regard to the time periods before and after the promulgation of the guidelines, but also from the point of time when the respective delivery unit actually implemented the guidelines. The results of these two methods were generally compatible, showing odds ratios of similar magnitude and trend. The analyses demonstrated a risk reduction for early-onset GBS disease of approximately 50% in infants of parturients presenting with one or more risk factors after change of practices. There was also a significant decrease in cases with clinical GBS infection where the bacteria could not be isolated in culture from blood or CSF. Yet many instances of missed opportunities for administration of IAP were identified. As expected with a risk-based prophylaxis strategy, there was no reduction at all of early-onset GBS morbidity in infants of mothers without risk factors.
Use of IAP might disguise true sepsis by rendering infant blood cultures negative, due to prenatal transfer of antibiotics. This assumption is supported by the fact that a significantly larger proportion of infants with clinical sepsis had mothers given any IAP as compared with infants with verified sepsis, 36 vs. 8%. However, the total number of infants with clinical sepsis was also markedly reduced over time, suggesting that the total burden of early-onset GBS morbidity was notably abridged by more consistent use of risk factor-based IAP. Table 3 . Early-onset group B streptococcal (GBS) infection cases and intrapartum antibiotic prophylaxis (IAP) administration in parturients with one or more risk factors, in units after local implementation of guidelines.
Timing of IAP and duration of labor.
† indicates fatal cases.
The strengths of this study are the population-based design comparing early-onset GBS infection occurring before and after the intervention, the multiple sources of data that can be successfully merged into one database using the unique personal number of mothers and infants, and the high recovery rate of clinical records. Furthermore, detailed data on the course of parturition and timing of IAP administration were registered. The design of this investigation is concordant with a previous study allowing an even longer time line for assessment of the impact of infant early-onset GBS morbidity in Sweden (17) . The recovered clinical data were also scrutinized by 2 independent investigators reaching consensus in cases of ambiguity.
Limitations of the study are the retrospective observational design and the fact that the introduction of the clinical intervention, i.e. national guidelines for risk-based IAP, did obviously not sharply alter clinical practices at the point of time when the guidelines were proclaimed. Approximately one-third of the delivery units had the practice in use before the official recommendation was issued and the rest of the units starting gradually during the year of promulgation or later, during the second observational period. Nor is there any information on the degree of adherence to the guidelines in units where they were endorsed. There were 17 cases with provisional identification numbers and positive blood culture for GBS who were identified from laboratory reports only. It is possible that several of these infants are among the 47 infants where clinical records were missing, but it cannot be definitely ruled out that there may be duplicates if the infant was referred to a regional hospital and given a second provisional identification number. The fact that one of the methods for statistical evaluation (method B) includes only infants with unique identification, indicates that outcomes would not be substantially altered by omitting these 17 cases.
The use of IAP has successfully reduced the burden of early-onset GBS infection in the newborn. Reports from countries with different strategies show that both screening-based and risk-based administration of IAP reduces the incidence of the disease. In a surveillance area in the United States with population based information, the incidence of verified infection has lowered to 0.26& of live births (2) . A similar figure was reached in New Zealand using the risk-based approach (22) . Analysis of local Swedish data from the Stockholm area, comprising 1/3 of all newborns in Sweden, has also shown a significant reduction of neonatal early-onset GBS sepsis after the introduction of risk-based guidelines (23) . Reports from the Netherlands are somewhat equivocal. Trijbel-Smeulders, et al. reported a reduction in the incidence of verified sepsis from 0.56 to 0.32& of live births after the introduction of risk-based prevention in 1999 (24) . In contrast, Becker, et al. found an increasing trend, although the overall incidence was low, reaching a maximum of 0.2& by the end of the observational period. The authors argue that the low incidence could possibly be due to underreporting of cases (25) . In the UK and Wales, an increasing incidence up to 0.41& was reported (26) despite an ongoing prevention program based on risk-based IAP (10). In the two latter studies, only laboratory data was used to acquire cases.
In Sweden, with a high prevalence of GBS-carriage (16) and relatively low rate of early-onset GBS disease, the national consensus group favored the risk-based approach. One argument was also that early-onset GBS infants of mothers without risk factors had a better prognosis. In the cohort from 1997 to 2001 no deaths occurred in cases where risk factors were not present (17) . The current inventory to some degree rebuts this point, in that three of 11 deaths occurred in cases where the mother had no risk factors and there were 14 cases with GBS meningitis. The results of the present study will provide background data for an appraisal of the current Swedish guidelines. 
Mode of delivery
All n = 355 n (%) Risk factor one or more n = 201 n (%) No risk factor n = 154 n (%)
Cesarean section 96 (27) IAP administration, according to the guidelines, should be started after onset of labor and optimally given four or more hours, and not later than two hours, before the estimated time of parturition (27) . After implementation of the guidelines locally, there were still many cases of parturients with risk factors who did not receive IAP. Several previous reports on the results of preventive strategies state that many opportunities to administer IAP are missed and that a stricter adherence to guidelines could have reduced the incidence of early-onset GBS disease even further (28) (29) (30) . The current study concurs with this conclusion, showing that in a large proportion of cases where IAP was indicated but not adequately given, there was probably enough time to do so. The most important issue in the mission to reduce early-onset GBS infection is undoubtedly to increase adherence to guidelines regardless of the preferred strategy.
The promulgation of national risk-based guidelines for IAP administration in Sweden coincided with a 50% risk reduction for infant early-onset GBS morbidity in parturients with at least one risk factor present. Yet there were many missed opportunities to provide IAP when indicated and stricter adherence to guidelines seems to be possible. This could most probably reduce the number of infant cases further.
